DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway.
- Written by PR Newswire
![]() |
HIGHLIGHTS
- Topline data from Clarity's diagnostic Phase II trial, DISCO, confirms that 64Cu-SARTATE is safe and highly effective compared to standard-of-care (SOC) imaging at detecting lesions in patients with neuroendocrine tumours (NETs).
- DISCO compared the diagnostic performance of 64Cu-SARTATE at an average of 4 hours (between 3 to 5...